Hyperglycemia with antipsychotic treatment.

Abstract

Diabetes and mental disorders are common chronic illnesses in the United States. Recently, the introduction of a new class of atypical antipsychotic medications has been a major treatment advance for patients with mental disorders. Because of increased use of atypical antipsychotic medications, new and unanticipated side effects have often appeared. Treatment-emergent diabetes has been described for conventional and atypical antipsychotics. People with schizophrenia may be at increased risk for type 2 diabetes because of the side effects of antipsychotic medication, underlying predisposition, and less healthy lifestyles.

• Authors: Roopa Sathyaprakash, Robert R Henry
• Journal: Current diabetes reports (Curr Diab Rep) Vol. 4 Issue 1 Pg. 41-5 (Feb 2004) ISSN: 1534-4827 [Print] United States
• PMID: 14764279 (Publication Type: Journal Article, Review)

Chemical References

• Antipsychotic Agents
• Insulin

Topics

• Antipsychotic Agents (adverse effects)
• Humans
• Hyperglycemia (chemically induced, psychology)
• Insulin (metabolism)
• Schizophrenia (blood, complications)
• Weight Gain